Clinical Trial Update: A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned [Phase 2]

View source ↗

Summary

A Phase 2 study of pemetrexed in small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Small Cell | Phase 2 | Status: COMPLETED